Dylan Wilson joined the MJ team as a client executive in our Risk Management + Commercial Insurance department. With a focus on the construction industry, Dylan oversees the entire lifecycle of our clients’ multi-year risk treatment strategies. In his role, Dylan collaborates with various teams including Analytics, Risk Services, Risk Transfer, Claims Consulting, and Client Advocacy to ensure flawless execution of MJ’s renowned consulting process. His expertise and attention to detail ensure that our clients receive top-notch service and tailored risk management solutions.
Prior to MJ, Dylan acquired over a decade of experience in underwriting and production underwriting. Having previously held prestigious positions such as a senior regional director, regional director, sales rover and senior underwriter, Dylan brings a wealth of knowledge to the MJ team.
Related Blogs
Gag Clause Prohibition and Attestation Requirement
Effective in 2020, the Consolidated Appropriations Act, 2021 (CAA) prohibits health plans and health insurance issuers from entering into contracts with health care providers, ...
Read More
HHS Releases Hardship Exemption Guidance for Catastrophic Coverage
On Sept. 4, 2025, the U.S. Department of Health and Human Services (HHS) issued guidance describing circumstances under which individuals who are enrolling in ...
Read More
U.S. Average Breach Cost Hits Record High of $10.22 Million
The average cost of a data breach in the U.S. soared to an all-time high of $10.22 million, even as the global average cost ...
Read More
The MJ Foundation Names Four Local Nonprofits in Indianapolis, Phoenix, Denver, and Nashville as New Charities of Choice
INDIANAPOLIS (Sept. 10, 2025) – The MJ Charitable Foundation (the MJ Foundation), has named four nonprofits in the Indianapolis, Phoenix, Denver, and Nashville community ...
Read More
The MJ Companies Named a 2025 Best Practices Agency
The MJ Companies retained its Best Practices status for 2025, joining an elite group of independent insurance agencies from across the United States. The ...
Read More
WHAT LOOKS LIKE A PHARMACY BENEFIT SOMETIMES ISN’T: THE J-CODE CONUNDRUM
From what I’ve seen, more than three quarters of employers are facing at least one J-code issue. And because medically administered and infused drugs ...
Read More